Disclosure 0001491874-26-000005-1

SEC FORM 4

$48,698.28

Allogene Therapeutics, Inc. (ALLO)

Sale of 36,342 shares at $1.34 per share.

Reporting Person Parker Geoffrey M. · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001491874-26-000005 · filed 2026-10-23 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Allogene Therapeutics, Inc. (ALLO)." Disclosed 2026-10-23. https://desqlong.com/cards/0001491874-26-000005-1 (retrieved 2026-10-24).